Xiaolin Ni

741 total citations
34 papers, 475 citations indexed

About

Xiaolin Ni is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Xiaolin Ni has authored 34 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Xiaolin Ni's work include Genetics, Aging, and Longevity in Model Organisms (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Diabetes and associated disorders (3 papers). Xiaolin Ni is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Diabetes and associated disorders (3 papers). Xiaolin Ni collaborates with scholars based in China, Netherlands and United States. Xiaolin Ni's co-authors include Dayong Jin, Wenchuan Wu, Yefei Rong, Dansong Wang, Wenhui Lou, Huiping Yuan, Xiaoquan Zhu, Tiantao Kuang, Ze Yang and Liang Sun and has published in prestigious journals such as PLoS ONE, Journal of Affective Disorders and Cell Reports.

In The Last Decade

Xiaolin Ni

33 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Ni China 11 175 129 124 85 82 34 475
Jonathan C. Jaoude United States 7 232 1.3× 117 0.9× 55 0.4× 51 0.6× 66 0.8× 9 394
Henglei Lu China 12 194 1.1× 110 0.9× 68 0.5× 38 0.4× 110 1.3× 20 429
Lizhi Lv China 13 235 1.3× 150 1.2× 100 0.8× 31 0.4× 81 1.0× 42 487
Wei Zou China 11 225 1.3× 52 0.4× 136 1.1× 66 0.8× 44 0.5× 28 580
Yinyun Ni China 11 243 1.4× 143 1.1× 143 1.2× 92 1.1× 58 0.7× 22 646
Hye‐Rim Park South Korea 13 340 1.9× 65 0.5× 123 1.0× 50 0.6× 57 0.7× 37 530
Yaqi Xing China 4 243 1.4× 93 0.7× 54 0.4× 48 0.6× 64 0.8× 7 425
İlhan Yaylım Türkiye 13 173 1.0× 77 0.6× 82 0.7× 42 0.5× 22 0.3× 59 438

Countries citing papers authored by Xiaolin Ni

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Ni more than expected).

Fields of papers citing papers by Xiaolin Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Ni. The network helps show where Xiaolin Ni may publish in the future.

Co-authorship network of co-authors of Xiaolin Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Ni. A scholar is included among the top collaborators of Xiaolin Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Ni. Xiaolin Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ni, Xiaolin, Ting-Wei Chen, Jixin Wang, et al.. (2025). Genetic determinants of gene expression noise and its role in complex trait variation. Cell Reports. 44(12). 116612–116612.
2.
Ni, Xiaolin, et al.. (2025). Growth Hormone Improves Ovarian Follicle Health in Premature Ovarian Failure Mice by Reducing Apoptosis. Reproductive Sciences. 32(5). 1730–1742. 1 indexed citations
3.
Xu, Xiaomeng, et al.. (2024). Constructing Safety Management Systems in Modern Industry and Trade Enterprises: A STAMP-Based Approach. Sustainability. 16(24). 11238–11238. 2 indexed citations
5.
Ni, Xiaolin, et al.. (2023). Modifiable pathways for longevity: A Mendelian randomization analysis. Clinical Nutrition. 42(6). 1041–1047. 6 indexed citations
6.
Ni, Xiaolin, Ze Yang, Yuan Lv, et al.. (2023). Development of a model for the prediction of biological age. Computer Methods and Programs in Biomedicine. 240. 107686–107686. 6 indexed citations
7.
Ni, Xiaolin, Xiuqing Huang, Mingjun Jiang, et al.. (2023). The relationship between sleep duration and activities of daily living (ADL) disability in the Chinese oldest-old: A cross-sectional study. PeerJ. 11. e14856–e14856. 9 indexed citations
8.
Ni, Xiaolin, Xiuqing Huang, Mingjun Jiang, et al.. (2023). Exploration for the reference interval of C-reactive protein in the Chinese longevity people over 90 years of age. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 17(8). 102817–102817. 3 indexed citations
9.
Ni, Xiaolin, Lei Liu, Yao Yao, et al.. (2023). The genetic correlation and causal association between key factors that influence vascular calcification and cardiovascular disease incidence. Frontiers in Cardiovascular Medicine. 10. 1096662–1096662. 3 indexed citations
10.
Ni, Xiaolin, Di Zhang, Qing Chen, et al.. (2022). The major risk factor for depression in the Chinese middle-aged and elderly population: A cross-sectional study. Frontiers in Psychiatry. 13. 986389–986389. 12 indexed citations
11.
Li, Chen, et al.. (2022). Recent evidence in support of traditional chinese medicine to restore normal leptin function in simple obesity. Heliyon. 8(5). e09482–e09482. 5 indexed citations
12.
Ni, Xiaolin, Liang Sun, Xiaoquan Zhu, et al.. (2021). Investigation of the Reference Interval Values of Fasting Plasma Glucose, Blood Pressure, and Blood Lipids in the Longevity People Aged 90 Years Old and Above. Diabetes Metabolic Syndrome and Obesity. Volume 14. 3711–3718. 1 indexed citations
13.
Guo, Yanfei, Jie Liu, Xiuqing Huang, et al.. (2021). Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis. PeerJ. 9. e12384–e12384. 7 indexed citations
15.
Chen, Chen, Qi Zhou, Ruiyue Yang, et al.. (2021). Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011–2014). Ecotoxicology and Environmental Safety. 218. 112295–112295. 49 indexed citations
16.
Ni, Jian, Xiaolin Ni, Nan Zhang, et al.. (2021). Association of CYP24A1 gene polymorphism with colorectal cancer in the Jiamusi population. PLoS ONE. 16(6). e0253474–e0253474. 5 indexed citations
17.
Ni, Xiaolin, Li Zhang, Liang Sun, et al.. (2020). <p>Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 4261–4272. 19 indexed citations
18.
Li, Wentao, Xia Yang, Yubin Li, et al.. (2015). Microwave ablation as palliative treatment of locally recurrent colorectal cancer. Indian Journal of Cancer. 52(6). 61–61. 5 indexed citations
19.
Ni, Xiaolin, et al.. (2013). Glioblastoma Tumor Initiating Cells: Therapeutic Strategies Targeting Apoptosis and MicroRNA Pathways. Current Molecular Medicine. 13(3). 352–357. 24 indexed citations
20.
Rong, Yefei, Dayong Jin, Jianwen Hu, et al.. (2010). Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2. BMC Gastroenterology. 10(1). 68–68. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026